Zapanta, J. B., and C. Gorospe. “Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer After Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report”. Asian Pacific Journal of Cancer Care, Vol. 10, no. 3, July 2025, pp. 989-92, doi:10.31557/apjcc.2025.10.3.989-992.